- We will send in 10–14 business days.
/images/books/4799364/9781009336130.jpg)
- Author: Matthew Lee
- Publisher: Cambridge University Press
- ISBN-10: 1009336134
- ISBN-13: 9781009336130
- Format: 15.2 x 22.9 x 0.5 cm, minkšti viršeliai
- Language: English
- SAVE -10% with code: EXTRA
Reviews
Description
The recent advances in the field of molecular diagnostic techniques have led to the identification of targetable alterations prompting a paradigm shift in the management of non-small cell lung cancer (NSCLC) and an era of precision oncology. This Element highlights the most clinically relevant oncogenic drivers other than EGFR, their management and current advancements in treatment. It also examines the different challenges in resistance to targeted therapies and diagnostic dilemmas for each oncogenic driver and the future direction of NSCLC management.
EXTRA 10 % discount with code: EXTRA
The promotion ends in 21d.12:06:45
The discount code is valid when purchasing from 10 €. Discounts do not stack.
- Author: Matthew Lee
- Publisher: Cambridge University Press
- ISBN-10: 1009336134
- ISBN-13: 9781009336130
- Format: 15.2 x 22.9 x 0.5 cm, minkšti viršeliai
- Language: English English
The recent advances in the field of molecular diagnostic techniques have led to the identification of targetable alterations prompting a paradigm shift in the management of non-small cell lung cancer (NSCLC) and an era of precision oncology. This Element highlights the most clinically relevant oncogenic drivers other than EGFR, their management and current advancements in treatment. It also examines the different challenges in resistance to targeted therapies and diagnostic dilemmas for each oncogenic driver and the future direction of NSCLC management.
Reviews